首页> 外文期刊>La Presse Médicale Formation. >Troubles anxieux, troubles dépressifs, conduites suicidaires et cannabis
【24h】

Troubles anxieux, troubles dépressifs, conduites suicidaires et cannabis

机译:焦虑症,抑郁症,自杀管和大麻

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Many patients report self-medicate anxiety or depressive symptoms. They actually self-medicate subthreshold withdrawal symptoms due to cannabis addiction. Patients with severe cannabis use disorders experience on a doily basis subthreshold withdrawal anxiety and depressive symptoms, characterized by irritability, anger, aggression, and craving for cannabis. The integrated approaches of patients with dual diagnosis include treatments of both anxiety disorders or depressive disorders and cannabis use disorders treatments. Nicotine dependence, personality disorders, or childhood maltreatments, may be risk factors both for cannabis use disorders and anxiety disorders or depressive disorders. Motivational interviewing aims to disentangle anxiety or depressive symptoms linked to primary anxiety disorders or depressive disorders from subthreshold withdrawal symptoms due to cannabis addiction.
机译:许多患者报告自我药物焦虑或抑郁症状。 他们实际上是由于大麻成瘾引起的自我药物阈值戒断症状。 严重大麻使用障碍的患者在阈下抑制戒断焦虑和抑郁症状,其特征是烦躁,愤怒,侵略和对大麻的渴望。 双重诊断患者的综合方法包括治疗焦虑症或抑郁症和大麻使用障碍治疗。 尼古丁依赖性,人格障碍或儿童虐待可能是大麻使用障碍和焦虑症或抑郁症的危险因素。 动机访谈旨在消除与原发性焦虑症或抑郁症有关的焦虑或抑郁症状,从大麻成瘾引起的亚阈值戒断症状。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号